No fees unless we win.
Get a free consultation
According to NJ.com, a former Johnson & Johnson sales representative who served as a whistleblower and helped the U.S. government secure a $2.2 billion settlement over the manufacturer’s off-label marketing of Risperdal said sales of the anti-psychotic medicine accounted for 70% of employee bonuses.
The website reported that Judy Doetterl claimed that the manufacturer marketed Risperdal, and two other drugs for off-label uses, paying kickbacks to doctors and pharmacists who helped boost sales. Last year, during a settlement, J&J pleaded guilty to misbranding the drugs.
Doetterl worked in North Carolina for three years, promoting Risperdal for on-label uses to psychiatrists before moving to the ElderCare division in Buffalo, according to NJ.com. The website reported that she was then asked to sell Risperdal for dementia patients, working under a compensation plan that paid her for off-label sales.
Risperdal is an antipsychotic drug used to treat schizophrenia and manic states often associated with bipolar disorder. It has been linked to rashes, hyperprolactinaemia, nausea, vomiting, dizziness, agitation, anxiety, as well as stroke and seizures.
Outside of the $2.2 billion court settlement associated with criminal charges last year, J&J agreed to pay $181 million in 2012 to 36 states after it was accused of promoting the drug for unapproved uses. The company also settled hundreds of lawsuits in 2012 from men who claimed that the drug caused them to grow additional breast tissue.
If you have been injured or are suffering because you took a dangerous drug like Risperdal, we can help you. Contact our experienced mass tort and defective medical device lawyers by calling toll-free (888)841-9623 today.
Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers
Source: http://www.nj.com/business/index.ssf/2013/12/johnson_johnson_risperdal_whis.html
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
